Downstream effects on human low density lipoprotein of homocysteine exported from endothelial cells in an in vitro system Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400339-JLR200
暂无分享,去创建一个
H. Griffiths | S. Aldred | H. Powers | E. Nakano | D. Nugent | F. Taiwo | M. Paisi | S. Moat | P. Bhatt | M. Kwok | M. H. Hill | M. Paisi
[1] S. Duthie,et al. Effect of folic Acid supplementation on the folate status of buccal mucosa and lymphocytes. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[2] H. Powers,et al. Copper-mediated LDL oxidation by homocysteine and related compounds depends largely on copper ligation. , 2004, Biochimica et biophysica acta.
[3] B. Hultberg. Modulation of extracellular homocysteine concentration in human cell lines. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[4] H. Blom,et al. Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. , 2003, The American journal of clinical nutrition.
[5] K. Woollard,et al. Direct modulatory effect of C‐reactive protein on primary human monocyte adhesion to human endothelial cells , 2002, Clinical and experimental immunology.
[6] J. Higgins,et al. Folate protects against oxidative modification of human LDL , 2001, British Journal of Nutrition.
[7] V. Stevens,et al. Folate receptor function is regulated in response to different cellular growth rates in cultured mammalian cells. , 2001, The Journal of nutrition.
[8] M. Burkitt. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin. , 2001, Archives of biochemistry and biophysics.
[9] S. Sengupta,et al. Albumin Thiolate Anion Is an Intermediate in the Formation of Albumin-S–S-Homocysteine* , 2001, The Journal of Biological Chemistry.
[10] P. Durand,et al. Impaired Homocysteine Metabolism and Atherothrombotic Disease , 2001, Laboratory Investigation.
[11] L. H. Patterson,et al. Electron paramagnetic resonance spectrometry evidence for bioreduction of tirapazamine to oxidising free radicals under anaerobic conditions. , 2000, Biochemical pharmacology.
[12] M. Brosnan,et al. Characterization of homocysteine metabolism in the rat liver. , 2000, The Biochemical journal.
[13] S. Vollset,et al. The controversy over homocysteine and cardiovascular risk. , 2000, The American journal of clinical nutrition.
[14] R. Glynn,et al. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? , 2000, Archives of internal medicine.
[15] R. Green,et al. Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. , 1999, Advances in enzyme regulation.
[16] J. Bonham,et al. Recommended Approaches for the Laboratory Measurement of Homocysteine in the Diagnosis and Monitoring of Patients with Hyperhomocysteinaemia , 1999, Annals of clinical biochemistry.
[17] J. Joseph,et al. Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: antioxidant implications. , 1999, Free radical biology & medicine.
[18] B. Hultberg,et al. Higher export rate of homocysteine in a human endothelial cell line than in other human cell lines. , 1998, Biochimica et biophysica acta.
[19] A. Graham,et al. Cellular thiol production and oxidation of low-density lipoprotein. , 1998, Free radical research.
[20] M. Law,et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. , 1998, Archives of internal medicine.
[21] S. Vollset,et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.
[22] J. Witteman,et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.
[23] W. Vermaak,et al. Spontaneous oxidation of methionine: effect on the quantification of plasma methionine levels. , 1997, Analytical biochemistry.
[24] E. Schnitzer,et al. The effect of albumin on copper-induced LDL oxidation. , 1997, Biochimica et biophysica acta.
[25] B. Vedie,et al. Oxidative modification of low-density lipoprotein by the human hepatoma cell line HepG2. , 1996, Free radical research.
[26] H. Blom,et al. The effect of folic acid on the homocysteine metabolism in human umbilical vein endothelial cells (HUVECs) , 1996, European journal of clinical investigation.
[27] G. Omenn,et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.
[28] K. Bønaa,et al. Serum total homocysteine and coronary heart disease. , 1995, International journal of epidemiology.
[29] B. Halliwell,et al. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. , 1995, The American journal of clinical nutrition.
[30] H. Blom,et al. Lipid peroxidation and susceptibility of low‐density lipoprotein to in vitro oxidation in hyperhomocysteinaemia , 1995, European journal of clinical investigation.
[31] A. Chait,et al. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. , 1993, Journal of lipid research.
[32] P. Ueland,et al. Total homocysteine in plasma or serum: methods and clinical applications. , 1993, Clinical chemistry.
[33] J Olszewski,et al. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. , 1993, Journal of lipid research.
[34] P. Ueland,et al. Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration. , 1993, Clinical chemistry.
[35] D. Wilcken,et al. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[36] W. Willett,et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.
[37] P. Ueland,et al. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. , 1992, Analytical biochemistry.
[38] O. Vintermyr,et al. Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: Methionine loading of non‐transformed, transformed, proliferating, and quiescent cells in culture , 1991, Journal of cellular physiology.
[39] A. Chait,et al. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. , 1987, The Journal of biological chemistry.
[40] D. A. Jencks,et al. Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. , 1987, The Journal of biological chemistry.
[41] P. Riesz,et al. On the spin trapping and ESR detection of oxygen-derived radicals generated inside cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Chait,et al. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. , 1986, The Journal of clinical investigation.
[43] T. Ishii,et al. Transport of cystine and cysteine and cell growth in cultured human diploid fibroblasts: Effect of glutamate and homocysteate , 1982, Journal of cellular physiology.
[44] H. Itabe. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. , 2003, Biological & pharmaceutical bulletin.
[45] I. Pogribny,et al. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations. , 2000, Clinical chemistry.
[46] H. Griffiths,et al. Oxidative modification of a specific apolipoprotein B lysine residue confers altered receptor specificity on LDL. , 1999, Redox report : communications in free radical research.
[47] S. Hopfer,et al. Measurement of maternal folate status and risk of neural tube defects. , 1997, Clinical chemistry.
[48] J. Berliner,et al. The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.
[49] P. Ueland,et al. Effect of Methionine and Nitrous Oxide on Homocysteine Export and Remethylation in Fibroblasts from Cystathionine Synthase-Deficient, cblG, and cblE Patients , 1994, Pediatric Research.
[50] S. Mudd. Disorders of transsulfuration , 1989 .
[51] Charles R.scriver. The Metabolic basis of inherited disease , 1989 .
[52] S. Aust,et al. Microsomal lipid peroxidation. , 1978, Methods in enzymology.
[53] P. Talalay,et al. Enzymic isomerization of Δ5-3-ketosteroids , 1955 .